insights_auto
Kwa nini RHHBF imeongezeka kwa 4.01%?
Fahamu zaidichevron_right
RHHBF:OTCMKTS
Roche Holding AG
US$Â 460.00
arrow_upward
+4.01%(+17.73) Siku 1
14 Okt, 16:00:00 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya RHHBF...
Fungua
US$Â 460.00
Juu
US$Â 460.00
Chini
US$Â 460.00
Mtaji wa soko
362.68B
Wastani wa kiasi cha mauzo
61.00
Kiasi cha mauzo ya hisa
70.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
199.84
Juu kwa wiki 52
US$Â 514.08
Chini kwa wiki 52
US$Â 301.27
EPS
US$Â 2.30
Beta
0.45
Hisa za wawekezaji
106.69M
Idadi ya wafanyakazi
elfu 113
Fungua
US$Â 460.00
Juu
US$Â 460.00
Chini
US$Â 460.00
Mtaji wa soko
362.68B
Wastani wa kiasi cha mauzo
61.00
Kiasi cha mauzo ya hisa
70.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
199.84
Juu kwa wiki 52
US$Â 514.08
Chini kwa wiki 52
US$Â 301.27
EPS
US$Â 2.30
Beta
0.45
Hisa za wawekezaji
106.69M
Idadi ya wafanyakazi
elfu 113
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
saa 3 zilizopita
Roche presents vamikibart data. Roche Holding stock is valued at CHF 326.6 billion
TipRanks
·
siku 1 iliyopita
Nurix Therapeutics’ High-Stakes Reliance on Roche: Cost Burdens, Control Risks and Uncertain Returns for Lead Drug Bexobrutideg
ad-hoc-news.de
·
siku 1 iliyopita
Hapvida signs Roche deal: target for Hapvida stock falls 10.77 percent
Reuters
·
siku 1 iliyopita
Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics
Wasifu
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
Kuhusu Roche Holding AG
Afisa Mkuu Mtendaji (CEO)Thomas Schinecker
Wafanyakazielfu 113
Lilianzishwa1 Okt 1896
Makao makuuBasel, Mji wa Basel, Uswisi
Sekta-
Tovutiroche.com